Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on September 28, 2026

Sep. 28, 2026

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

Sep. 28, 2026

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

Sep. 28, 2026

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire

Sep. 28, 2026

NOTICE TO DISREGARD -- Direct Meds

Indeterminate GlobeNewswire

Sep. 28, 2026

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Indeterminate GlobeNewswire

Sep. 28, 2026

Flyte Named Official Air Travel Partner of the 34th Annual Hamptons International Film Festival

Indeterminate GlobeNewswire

Sep. 28, 2026

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire

Sep. 28, 2026

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire

Sep. 28, 2026

Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors

Indeterminate GlobeNewswire

Sep. 28, 2026

إطلاق نهج طبي دولي جديد رسمياً في شنتشن بالصينيهدف إلى عكس مسار السكري

Indeterminate GlobeNewswire

Sep. 28, 2026

A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China

Indeterminate GlobeNewswire

Sep. 28, 2026

Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno

Indeterminate GlobeNewswire

Sep. 28, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Indeterminate GlobeNewswire

Sep. 28, 2026

Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 28, 2026

Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités

Indeterminate GlobeNewswire

Sep. 28, 2026

OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire

Sep. 28, 2026

OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2026 et fait un point sur ses activités

Indeterminate GlobeNewswire

Sep. 28, 2026

JJP Biologics to Present Data Showing the Potential of Nebaprubart for Linear IgA Dermatosis (LAD) at Two Key Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Sep. 28, 2026

Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update

Indeterminate GlobeNewswire